| Indications for thrombolysis in deep venous thrombosis. | |
| | |
MedLine Citation:
|
PMID: 19427243 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: Deep venous thromboses (DVTs) are a significant cause of morbidity and mortality in the general and inpatient population. Current anticoagulation therapy is efficient in reducing thrombus propagation but does not contribute to clot lysis or prevention of post-thrombotic limb syndrome. Catheter directed thrombolysis (CDT) is an alternative method for treating DVTs but there is no consensus regarding indications for its use. DATA SOURCES: PubMed and Cochrane library were searched for all articles on deep vein thrombosis and thrombolysis. REVIEW METHOD: Articles presenting data on DVT thrombolysis, DVT anticoagulation, mechanical thrombectomy, venous stenting and May-Thurner's syndrome were considered for inclusion in the review. RESULTS: CDT reduced clot burden, DVT recurrence and may prevent the formation of post-thrombotic syndrome. Indications for its use include younger individuals with a long life expectancy and few co-morbidities, limb-threatening thromboses and proximal ilio-femoral DVTs. There is a marked lack of randomised controlled trials comparing CDT-related mortality and long term outcomes compared to anticoagulation alone. The effectiveness of combined pharmaco-mechanic thrombectomy, although promising, need to be further investigated, as is the role of caval filters in preventing DVT-associated pulmonary emboli. CONCLUSIONS: These results suggest that the outcome of CDT in DVT management are encouraging in selected patient cohorts, but further evidence is required to establish longer term benefits and cost-effectiveness. |
| | |
Authors:
|
P Gogalniceanu; C J C Johnston; U Khalid; P J E Holt; R Hincliffe; I M Loftus; M M Thompson |
Related Documents
:
|
556983 - Autoerthrocyte sensitization---a psychogenic purpura? 2183953 - Neurovascular injuries in the wrists and hands of athletes. 17465333 - A pathogenic mechanism leading to partial lipodistrophy and prospects for pharmacologic... |
Publication Detail:
|
Type: Journal Article; Review Date: 2009-05-07 |
Journal Detail:
|
Title: European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery Volume: 38 ISSN: 1532-2165 ISO Abbreviation: Eur J Vasc Endovasc Surg Publication Date: 2009 Aug |
Date Detail:
|
Created Date: 2009-07-20 Completed Date: 2009-08-03 Revised Date: 2011-08-25 |
Medline Journal Info:
|
Nlm Unique ID: 9512728 Medline TA: Eur J Vasc Endovasc Surg Country: England |
Other Details:
|
Languages: eng Pagination: 192-8 Citation Subset: IM |
Affiliation:
|
St George's Regional Vascular Institute, 4th Floor, St James' Wing, St George's Hospital NHS Trust, Tooting, London SW17 0QT, United Kingdom. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anticoagulants
/
therapeutic use Cost-Benefit Analysis Fibrinolytic Agents / adverse effects, economics, therapeutic use* Humans Patient Selection Postthrombotic Syndrome / etiology, prevention & control Quality of Life Recurrence / prevention & control Risk Assessment Stents Thrombectomy Thrombolytic Therapy* / adverse effects, economics, mortality Time Factors Treatment Outcome Venous Thrombosis / complications, drug therapy*, mortality |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 0/Fibrinolytic Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Professional Memory CD4(+) T Lymphocytes Preferentially Reside and Rest in the Bone Marrow.
Next Document: Iliac artery compression in cyclists: mechanisms, diagnosis and treatment.